Bovivax LSD-N

Bovivax LSD-N is a vaccine developed by M.C.I. Santé Animale (a subsidiary of Ceva Santé Animale) to protect cattle against Lumpy Skin Disease (LSD), a viral disease that affects cattle, causing nodules on the skin and other symptoms.

Composition:

• Active Ingredient: Each dose contains live attenuated Lumpy Skin Disease virus, strain Neethling, with a tissue culture infective dose (TCID50) of ≥ 10³.⁵ per dose.

Indications:

• Prophylactic immunization of cattle against Lumpy Skin Disease.

Contraindications:

• None specified; however, it is recommended to vaccinate only healthy animals. Administration:

• Administer a single subcutaneous injection of the reconstituted vaccine to cattle.

Storage Recommendations:

• Store the vaccine between +2°C and +8°C (35°F and 46°F).
• Protect from light to maintain vaccine efficacy.

Safety Precautions:

• Avoid contact with eyes, hands, and clothing during handling.
• In case of accidental self-injection, seek medical advice immediately and show the package leaflet or label to the physician.

Manufacturer:

• Produced by M.C.I. Santé Animale, Morocco.

For more detailed information, including administration techniques and handling, please refer to the official guidelines provided by M.C.I. Santé Animale or consult with a veterinary professional.